Seminars in Oncology
Volume 36, Issue 2 , Pages 126-136, April 2009

Ovarian Stromal and Germ Cell Tumors

  • Carolyn R. Koulouris
  • ,
  • Richard T. Penson

      Affiliations

    • Corresponding Author InformationAddress correspondence to Richard T. Penson, MD, MRCP, Division of Hematology Oncology, Massachusetts General Hospital, Yawkey 9066, 32 Fruit St, Boston, MA 02114

Division of Hematology Oncology, Massachusetts General Hospital, Boston, MA

Cancers arising from the stromal and germ cell layers of the ovary are rare, heterogeneous, difficult to study, and require specialized multidisciplinary management. We present a clinically relevant review of the literature of these malignancies, with particular emphasis on the more typical presentations. These tumors more commonly present in younger patients and have a high cure rate. They are associated with serum markers that are informative for diagnosis and surveillance. Surgery is often part of primary treatment, with staging and preservation of fertility being important priorities. Most patients with germ cell tumors require adjuvant chemotherapy with bleomycin, etoposide, and cisplatin (BEP), as well as careful surveillance. The rarity of these tumors makes basic scientific advances more challenging.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0093-7754(08)00261-3

doi:10.1053/j.seminoncol.2008.12.004

Seminars in Oncology
Volume 36, Issue 2 , Pages 126-136, April 2009